Are Sirius Minerals plc, Next Fifteen Communications Group plc and Clinigen Group plc the 3 hottest small-cap stocks around?

Should you pile into Sirius Minerals plc (LON: SXX), Next Fifteen Communications Group plc (LON: NFC) and Clinigen Group plc (LON: CLIN) right now?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The last year has been a rather exciting one for investors in advertising and PR specialist Next Fifteen (LSE: NFC). That’s because the company’s shares have risen by a whopping 37% as the outlook for the global economy has improved. Furthermore, the company has been able to increase its earnings by 78% and 36%, respectively, in the last two years, which has clearly caused investor sentiment towards Next Fifteen to improve dramatically.

Looking ahead, the uncertain outlook for the global economy could cause the pace of Next Fifteen’s share price rise to moderate somewhat. US interest rate increases appear very likely over the next year and this could cause investor sentiment towards cyclical stocks such as Next Fifteen to weaken. However, with the company having a sound business model that’s well-diversified, it may be able to continue to deliver upbeat growth numbers in the long run.

Certainly, earnings growth forecasts of 9% this year and 10% next year have huge appeal. And with Next Fifteen trading on a price-to-earnings growth (PEG) ratio of just 1.3, now seems to be an excellent time to buy a slice of it for the long run.

Worth a look

While Next Fifteen has enjoyed a strong year of share price growth, shares in healthcare company Clinigen (LSE: CLIN) have disappointed. That’s because they’ve fallen by 15% during the period despite Clinigen recording three successive years of double-digit growth.

In fact, Clinigen’s earnings per share have risen from 13.4p in 2012 to 28p in 2015. That’s an annualised rise of almost 28% and shows that Clinigen remains a very strong growth play. And with the company forecast to increase its bottom line by 21% in each of the next two years, investor sentiment could begin to pick up over the coming months.

That’s especially the case since Clinigen trades on a PEG ratio of just 0.6, which indicates that the market hasn’t yet begun to price-in its improving financial outlook. And with Clinigen having a beta of just 0.7, its shares could offer a less volatile shareholder experience in the short run. With the potential for increased uncertainty in the coming months, this could prove to be a major ally for the company’s investors.

Waiting game

Meanwhile, Sirius Minerals (LSE: SXX) has recorded a share price rise of 28% since the turn of the year, which brings its five-year capital gain to 100%. Clearly, that’s an impressive return, but Sirius Minerals has been a relatively risky investment during that time, with its success being heavily reliant on the approval of a major potash mine in York.

Although approval for the mine has now been granted, Sirius Minerals remains a relatively high-risk stock to own. It requires vast financing for such a large project and while investor sentiment towards the resources sector has improved of late, the commodity price collapse of recent years could still make fundraising more difficult for the firm.

Due to this, Sirius Minerals may be a stock to watch rather than buy at the moment – especially with a number of other smaller companies offering high growth and low valuations.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of Clinigen and Next Fifteen Communications. The Motley Fool UK has recommended Clinigen. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »